209 related articles for article (PubMed ID: 11791685)
1. Regional deposition of coarse particles and ventilation distribution in healthy subjects and patients with cystic fibrosis.
Brown JS; Zeman KL; Bennett WD
J Aerosol Med; 2001; 14(4):443-54. PubMed ID: 11791685
[TBL] [Abstract][Full Text] [Related]
2. Deposition of coarse particles in cystic fibrosis: model predictions versus experimental results.
Brown JS; Bennett WD
J Aerosol Med; 2004; 17(3):239-48. PubMed ID: 15625816
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of Particle Deposition by Pixel Analysis of 2D Gamma Scintigraphy Images.
Bennett WD; Xie M; Zeman K; Hurd H; Donaldson S
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):211-8. PubMed ID: 25393109
[TBL] [Abstract][Full Text] [Related]
4. Effect of Posture on Regional Deposition of Coarse Particles in the Healthy Human Lung.
Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
J Aerosol Med Pulm Drug Deliv; 2015 Dec; 28(6):423-31. PubMed ID: 25826480
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 133 xenon ventilation equilibrium scan (XV) and 99m technetium transmission (TT) scan for use in regional lung analysis by 2D gamma scintigraphy in healthy and cystic fibrosis lungs.
Zeman KL; Wu J; Donaldson SH; Bennett WD
J Aerosol Med Pulm Drug Deliv; 2013 Apr; 26(2):94-100. PubMed ID: 23421899
[TBL] [Abstract][Full Text] [Related]
6. Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia.
Regnis JA; Zeman KL; Noone PG; Knowles MR; Bennett WD
Exp Lung Res; 2000; 26(3):149-62. PubMed ID: 10813088
[TBL] [Abstract][Full Text] [Related]
7. Regional Ventilation Is the Main Determinant of Alveolar Deposition of Coarse Particles in the Supine Healthy Human Lung During Tidal Breathing.
Sá RC; Zeman KL; Bennett WD; Prisk GK; Darquenne C
J Aerosol Med Pulm Drug Deliv; 2017 Oct; 30(5):322-331. PubMed ID: 28277885
[TBL] [Abstract][Full Text] [Related]
8. Comparing lung regions of interest in gamma scintigraphy for assessing inhaled therapeutic aerosol deposition.
Biddiscombe MF; Meah SN; Underwood SR; Usmani OS
J Aerosol Med Pulm Drug Deliv; 2011 Jun; 24(3):165-73. PubMed ID: 21453048
[TBL] [Abstract][Full Text] [Related]
9. Optimum peripheral drug deposition in patients with cystic fibrosis.
Brand P; Meyer T; Häussermann S; Schulte M; Scheuch G; Bernhard T; Sommerauer B; Weber N; Griese M
J Aerosol Med; 2005; 18(1):45-54. PubMed ID: 15741773
[TBL] [Abstract][Full Text] [Related]
10. Targeting aerosol deposition in patients with cystic fibrosis: effects of alterations in particle size and inspiratory flow rate.
Laube BL; Jashnani R; Dalby RN; Zeitlin PL
Chest; 2000 Oct; 118(4):1069-76. PubMed ID: 11035679
[TBL] [Abstract][Full Text] [Related]
11. Optimization of aerosol deposition by pressure support in children with cystic fibrosis: an experimental and clinical study.
Fauroux B; Itti E; Pigeot J; Isabey D; Meignan M; Ferry G; Lofaso F; Willemot JM; Clément A; Harf A
Am J Respir Crit Care Med; 2000 Dec; 162(6):2265-71. PubMed ID: 11112150
[TBL] [Abstract][Full Text] [Related]
12. Comparative performance of two inhaler systems to assess distribution of convective ventilation by 99mTc-labeled aerosol scintigraphy in patients with airway obstruction.
Fazzi P; Borsò E; Albertelli R; Mariani G; Giuntini C
Q J Nucl Med Mol Imaging; 2009 Aug; 53(4):428-36. PubMed ID: 19174757
[TBL] [Abstract][Full Text] [Related]
13. RhDNase I aerosol deposition and related factors in cystic fibrosis.
Diot P; Palmer LB; Smaldone A; DeCelie-Germana J; Grimson R; Smaldone GC
Am J Respir Crit Care Med; 1997 Nov; 156(5):1662-8. PubMed ID: 9372691
[TBL] [Abstract][Full Text] [Related]
14. Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size.
Usmani OS; Biddiscombe MF; Barnes PJ
Am J Respir Crit Care Med; 2005 Dec; 172(12):1497-504. PubMed ID: 16192448
[TBL] [Abstract][Full Text] [Related]
15. Long-term clearance from small airways in patients with cystic fibrosis.
Lindström M; Camner P; Falk R; Hjelte L; Philipson K; Svartengren M
Eur Respir J; 2005 Feb; 25(2):317-23. PubMed ID: 15684297
[TBL] [Abstract][Full Text] [Related]
16. Regional deposition and retention of particles in shallow, inhaled boluses: effect of lung volume.
Bennett WD; Scheuch G; Zeman KL; Brown JS; Kim C; Heyder J; Stahlhofen W
J Appl Physiol (1985); 1999 Jan; 86(1):168-73. PubMed ID: 9887127
[TBL] [Abstract][Full Text] [Related]
17. Reduced effect of inhaled beta 2-adrenergic agonists on lung mucociliary clearance in patients with cystic fibrosis.
Mortensen J; Hansen A; Falk M; Nielsen IK; Groth S
Chest; 1993 Mar; 103(3):805-11. PubMed ID: 8095449
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of different scintigraphic approaches to assess pulmonary ventilation.
Magnant J; Vecellio L; de Monte M; Grimbert D; Valat C; Boissinot E; Guilloteau D; Lemarié E; Diot P
J Aerosol Med; 2006; 19(2):148-59. PubMed ID: 16796539
[TBL] [Abstract][Full Text] [Related]
19. Aerosolized protein delivery in asthma: gamma camera analysis of regional deposition and perfusion.
Sangwan S; Agosti JM; Bauer LA; Otulana BA; Morishige RJ; Cipolla DC; Blanchard JD; Smaldone GC
J Aerosol Med; 2001; 14(2):185-95. PubMed ID: 11681650
[TBL] [Abstract][Full Text] [Related]
20. Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man.
Ilowite JS; Smaldone GC; Perry RJ; Bennett WD; Foster WM
Arch Environ Health; 1989; 44(4):267-73. PubMed ID: 2782948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
